Diagnos Inc. (ADK.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 310 | 89 | 219 | 297 | 421 |
| Marketable Securities | 1,617 | 3,147 | N/A | 0 | 500 |
| Receivables | 195 | 152 | 148 | 243 | 324 |
| TOTAL | $2,200 | $3,466 | $407 | $575 | $1,289 |
| Non-Current Assets | |||||
| PPE Net | 190 | 170 | 257 | 248 | 253 |
| TOTAL | $190 | $170 | $257 | $248 | $253 |
| Total Assets | $2,391 | $3,636 | $664 | $823 | $1,542 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,072 | 2,691 | 976 | 169 | 125 |
| Accounts payable and accrued liabilities | 164 | 173 | 330 | 288 | 278 |
| Accrued Expenses | 138 | 158 | 191 | 172 | 184 |
| TOTAL | $1,478 | $3,117 | $1,622 | $719 | $659 |
| Non-Current Liabilities | |||||
| Long Term Debt | 139 | 202 | 1,946 | 1,900 | 832 |
| Deferred Revenues | N/A | 0 | 8 | 7 | 7 |
| TOTAL | $226 | $286 | $2,094 | $2,052 | $996 |
| Total Liabilities | $1,704 | $3,403 | $3,716 | $2,771 | $1,655 |
| Shareholders' Equity | |||||
| Common Shares | 49,626 | 44,964 | 37,700 | 35,915 | 35,680 |
| Retained earnings | -59,489 | -54,933 | -50,647 | -47,526 | -44,992 |
| Other shareholders' equity | 10,549 | 10,202 | 9,895 | 9,664 | 9,199 |
| TOTAL | $687 | $233 | $-3,052 | $-1,948 | $-114 |
| Total Liabilities And Equity | $2,391 | $3,636 | $664 | $823 | $1,542 |